James F. Blake
Pfizer (United States) · 91 works · 6,205 citations · h-index 37
Top works
- Computation of Brain−Blood Partitioning of Organic Solutes via Free Energy Calculations
- Consensus scoring for ligand/protein interactions
- A Next-Generation TRK Kinase Inhibitor Overcomes Acquired Resistance to Prior TRK Kinase Inhibition in Patients with TRK Fusion–Positive Solid Tumors
- Solvent effects on a Diels-Alder reaction from computer simulations
- Identification of the Clinical Development Candidate MRTX849 , a Covalent KRASG12C Inhibitor for the Treatment of Cancer
- Free energy of TIP4P water and the free energies of hydration of CH4 and Cl- from statistical perturbation theory
- Enhanced Hydrogen Bonding of Water to Diels-Alder Transition States. Ab Initio Evidence
- Examination of the Computed Molecular Properties of Compounds Selected for Clinical Development
- Identification of MRTX1133, a Noncovalent, Potent, and Selective KRAS G12D Inhibitor
- Chemoinformatics – predicting the physicochemical properties of 'drug-like' molecules
- Ab initio study of Diels-Alder reactions of cyclopentadiene with ethylene, isoprene, cyclopentadiene, acrylonitrile, and methyl vinyl ketone
- Structure and basicity of silyl ethers: a crystallographic and ab initio inquiry into the nature of silicon-oxygen interactions
- Novel Benzisoxazole Derivatives as Potent and Selective Inhibitors of Acetylcholinesterase
- Ab initio study of the SN2 reactions of hydroxide and hydroperoxide with chloromethane
- RET Solvent Front Mutations Mediate Acquired Resistance to Selective RET Inhibition in RET-Driven Malignancies
- Potent and Selective Mitogen-Activated Protein Kinase Kinase (MEK) 1,2 Inhibitors. 1. 4-(4-Bromo-2-fluorophenylamino)-1- methylpyridin-2(1H)-ones
- Substituent effects and transition structures for Diels-Alder reactions of butadiene and cyclopentadiene with cyanoalkenes
- Stereoselective Alkylations in Rigid Systems. Effect of Remote Substituents on π-Facial Additions to Lactam Enolates. Stereoelectronic and Steric Effects
- Investigation of solvent effects on pericyclic reactions by computer simulations
- Discovery and Preclinical Pharmacology of a Selective ATP-Competitive Akt Inhibitor (GDC-0068) for the Treatment of Human Tumors